Armis Biopharma is a clinical-stage biopharmaceutical company with a pipeline of targeted anti-infective therapeutics to address antibiotic resistance and healthcare-associated infections.
Our goal is to create a platform for the treatment and prevention of severe, localized, drug-resistant infections in the orthopedic, dermatological, and surgical markets.
- Prophylactic and therapeutic efficacy
- Reduced cost of care to payers and insurers
- Versatile platforms in the war on resistant and preventable infection